Altimmune Inc Stock Nasdaq
Equities
US02155H1014
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 31.25M | Sales 2025 * | 25M | Capitalization | 532M |
---|---|---|---|---|---|
Net income 2024 * | -59M | Net income 2025 * | -142M | EV / Sales 2024 * | 15 x |
Net cash position 2024 * | 63.88M | Net cash position 2025 * | 257M | EV / Sales 2025 * | 11 x |
P/E ratio 2024 * |
-8.92
x | P/E ratio 2025 * |
-5.96
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.22% |
Latest transcript on Altimmune Inc
Managers | Title | Age | Since |
---|---|---|---|
Vipin K. Garg
CEO | Chief Executive Officer | 67 | 18-11-29 |
Director of Finance/CFO | 66 | 21-12-30 | |
Anthony Blandin
CMP | Compliance Officer | - | 22-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mitchel Sayare
CHM | Chairman | 76 | 10-03-31 |
Mack Gill
BRD | Director/Board Member | 72 | 04-07-31 |
Philip Hodges
BRD | Director/Board Member | 56 | 03-08-31 |
1st Jan change | Capi. | |
---|---|---|
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |